The largest database of trusted experimental protocols

9 protocols using gen5 program

1

Quantifying Protein Concentration in BAL and Air Pouch

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein concentration in BAL and the air pouch lavage was quantified using the DC protein Assay kit (Bio-Rad; Hercules, CA, USA). Absorbance was measured at 750 nm by an absorbance plate reader (BIOTEK Instrument; Winooski, VT, USA) and the results were analyzed using the Gen 5 program (BIOTEK Instrument; Winooski, VT, USA).
+ Open protocol
+ Expand
2

Quantitative Immunofluorescence Analysis of Tumor Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunofluorescence staining was performed on tumor tissues. First, tumor tissue fixation was performed using 4% paraformaldehyde (Sigma-Aldrich, #HT5011). Next, heat-induced epitope retrieval was performed by incubating the tissue in 10 mM sodium citrate for 10 min. Subsequently, permeabilization was achieved by treating the tissue with 0.2% Triton X-100 (Sigma-Aldrich, #X100) for 5 min. To block nonspecific binding, the tissue was incubated in 5% skim milk for 40 min. Primary antibodies, including FOXP3 (eBioscience, San Diego, CA, USA, #11-5773-82), CD8 (eBioscience #53-0081-82), CD31 (Abcam, Cambridge, UK, #ab28364), F480 (Abcam #ab6640), CD163 (Abcam #ab182422), and CD206 (Abcam #ab64693), were used. The secondary antibodies used were FITC-conjugated AffiniPure F(ab’)2 fragment goat anti-rat IgG (H + L) (Jackson ImmunoResearch, West Grove, PA, USA, #112-096-003) and Cy3-conjugated AffiniPure F(ab’)2 fragment goat anti-rabbit IgG (H + L) (Jackson ImmunoResearch #111-166-003). The stained tissue was mounted using ProLong™ Gold Antifade Mountant with DAPI (Invitrogen, Waltham, MA, USA) #14-5773-82). Fluorescent images of the samples were captured using the Agilent BioTek Cytation 1 device. The images were analyzed using the Gen5 program (Version3, BioTek, Winooski, VT, USA) to extract relevant data and perform quantitative analysis.
+ Open protocol
+ Expand
3

Osteogenic Differentiation on Titanium Alloy Scaffolds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Experiment was performed in triplicate, and a total of 9 scaffolds of each group were used. Cells were collected 3, 7, and 14 days after plating. Media were removed, and scaffolds were rinsed twice with cold phosphate-buffered saline. For evaluation of mRNA expression on the titanium alloy scaffolds, adherent cells in each sample were lysed using TRIzol (Invitrogen, Carlsbad, CA). Cell lysates were collected by pipetting and centrifugation. Samples were kept frozen at 80°C for at least 24 hours. Total RNA in the cell lysates was collected by ethanol precipitation, according to the manufacturer's protocol. Total RNA was quantified using a spectrophotometer (PowerWave HT-BioTek Instruments) and the Gen5™ program (BioTek Instruments). From each total RNA sample, cDNA was generated using SuperScript VILO cDNA Synthesis (Invitrogen) in a standard 20 µl reaction using 50 ng of the total RNA. Subsequently, equal volumes of cDNA were used to program qPCR reactions specific for mRNAs encoding the early osteogenic marker Runx2 (Qiagen, Germantown, MD). The qRT-PCR reaction was performed in an Applied Biosystems 7900HT Real Time PCR System (Thermo Fisher Scientific, Waltham, MA, USA). Relative mRNA abundance was determined by the 2−ΔΔCt method and reported as a fold change. TiAlV scaffold at day 3 was used as control group. GAPDH abundance was used for normalization.
+ Open protocol
+ Expand
4

Quantifying ALDH1 Activity in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
The ALDH1 ELISA kit (ab155894, Abcam, Cambridge, MA, USA) was used to measure ALDH1 activity in BON and QGP-1 cells with different treatments. The reaction mixture of ALDH assay buffer and ALDH substrate was incubated for 60 min at 22 °C. Fluorescence values were recorded at Ex/Em 535/587 nm by the Gen5 program (BioTek, Winooski, VT, USA) and used to calculate ALDH activity, based upon the manufacturer’s instruction.
+ Open protocol
+ Expand
5

The Effect of Light and p-Coumaric Acid on the Growth of Brettanomyces bruxellensis

Check if the same lab product or an alternative is used in the 5 most similar protocols
B. bruxellensis LAMAP2480 strain was grown in 5ml of SD minimum medium (2% w/v glucose and 6.7g/l yeast nitrogen base (YNB; Difco Laboratories, Detroit, United States)) at 28°C until saturation (stationary phase). Then, 1×105 cells/ml were inoculated in 200μl of the same medium in the absence and presence of 100mg/l of pCA (Sigma-Aldrich, Inc.; United States) in triplicate on a Cell Culture Plate (SPL Life Sciences, Korea). The microplates were incubated at 28°C in the dark and at different light intensities using white fluorescent lamps at a light intensity of 2,500 lux and 4,000 lux. Varying light intensities were provided by adjusting the light with the help of Lux meter UNI-T UT 382 USB (Dongguan, China). Absorbance measurements were made at 600nm for 10days in the Epoch equipment (BioTek, United States), coupled to the Gen5 program (BioTek, United States).
The specific growth rate was determined by the slope of the exponential growth phase according to the equation xt=x0+μt, where xt and x0 represent the biomass in optical density (OD) at time t (h) and t=0, respectively (Barata et al., 2008 (link)). The lag phase was determined as described by Buchanan and Cygnarowicz (1990) (link). All experiments were performed in triplicate.
+ Open protocol
+ Expand
6

NADPH Oxidase Activity Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chemiluminescence analysis of lucigenin derivatives was used to determine the activity of NADPH oxidase in a suspension of membrane preparations of HL-60 cells. For this, 100 mg of total protein from the suspensions of the membrane preparations were placed in a 96-well microplate at a final volume of 200 µL with PBS and incubated at 37 °C for 30 min with the acrylonitrile derivatives. VAS2870 (20 µM) was used as a control of inhibition. Chemiluminescence was measured for 1 h at 2 min intervals with a Synnergy H1 hybrid luminometer multi-mode microplate reader and GEN5 program (Biotek Instruments, Inc., Winooski, VT, USA). The reaction started with the addition of 100 μM NADPH to the cell suspension (200 μL: 100 μg protein + PBS) containing 100 μM lucigenin. The activity was expressed as relative units of luminescence per second, relative to the control.
+ Open protocol
+ Expand
7

Spheroid Surface Area Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Surface area measurements (µm2) and micrographs of at least five spheroids per treatment point were recorded from day three (immediately before the BP treatment = time 0) and after 24 and 96 h of post-treatment. Spheroids were exposed to single compounds at concentrations 10, 20, 40, and 80 µM and 1, 2, 4, and 8 µM for 24 and 96 h, respectively, and their combinations at concentrations of 10 + 10 µM, 20 + 20 µM, and 40 + 40 µM and 1 + 1 µM, 2 + 2 µM, and 4 + 4 µM for 24 and 96 h, respectively (see Table 2). Average surface area measurements and micrographs were captured using Cytation 5 (BioTek, Winooski, VT, USA) with a built-in microscope and a wide-angle-view camera at 4× magnification, and analysis was performed using the Gen5 program (Software for imaging and microscopy, BioTek, USA, version 3.11). Experiments were repeated three times in independent biological replicates.
In each experiment, a negative control (cell medium), solvent control (cells exposed to 0.3% and 0.06% DMSO for 24 and 96 h, respectively), and positive control (15% DMSO) were included. Graphical and statistical analyses were performed using GraphPad 8 software by one-way analysis of variance (ANOVA) test with a Dunnett post hoc [p < 0.05 (*), p < 0.001 (**), p < 0.0001 (***) were considered statistically significant].
+ Open protocol
+ Expand
8

Quantifying HSV-1 Infection by GFP Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
A recombinant strain of HSV-1 (KOS-GFP-HSV-1) was used for all experiments. This strain facilitated the detection of infected cells via GFP reporter expression (Figure 5A). At 24 h post-infection, the Cytation 5 was used to image and quantify GFP-expressing cells (Figure 5B). Image analysis was performed using the Gen5 program (version 3.11) (Agilent Technologies, Santa Clara, CA, USA). Images were acquired using a 4x magnification lens with the brightfield high contrast and GFP channels. Total cells, GFP+ cells, and the mean fluorescent intensity (MFI) of each well were quantified from images captured at 4x magnification using the Cytation 5. The percentage of GFP+ cells was calculated by dividing the number of GFP+ cells by the total cell count for each image.
+ Open protocol
+ Expand
9

Wound Healing Assay for Inflammatory Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Wound healing assay studies changes in cell migration and proliferation under pro-inflammatory conditions. Confluent HaCaT cells grown on the 96-well plate were used for the assay. Half of the plates was treated with mitomycin at a final concentration of 1 μg/ml for 2 h to stop the proliferation and observe only migration. After PBS wash, the wounds were made by BioTek AutoScratch Wound Making Tool (Agilent, USA), the cells were washed again, supplemented with HaCaT culture medium, and treated with LPS as mentioned above. The cells were maintained in BioTek BioSpa 8 Automated Incubator (Agilent) and photos of the wounds were acquired by BioTek Cytation 5 Imaging Reader (Agilent) each 6 h for 24 h. The area of the wounds was calculated in the Gen5 program (Agilent).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!